Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


Medication dosing could be 'poisoning' older people because of age exclusion in clinical trials


People with intellectual disabilities and medical research. People with intellectual/learning disabilities (ID) are exposed to the same medical interventions as everyone else. They experience the same illnesses often at a younger age than the general population. They are often prescribed multiple medications. People with ID often have unique health profiles and may not react to medications and medical treatments the same as people without ID. One study (1) found that only 6 (2%) of 300 randomly chosen studies clearly included persons with ID. Over 90% of studies were designed in ways that would automatically exclude people with ID from participating. The findings of this study highlight the exclusion of people with ID in medical research. This fact may not be widely known. J Intellect Disabil Res. 2014 Sep;58(9):800-9. doi: 10.1111/jir.12091. Epub 2013 Sep 3. Where are persons with intellectual disabilities in medical research? A survey of published clinical trials. Feldman MA(1), Bosett J, Collet C, Burnham-Riosa P.

Posted date

4 NOV 2019

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.